iRGD is a 9-amino acid cyclic peptide that exhibits anti-inflammatory and analgesic properties.  Irgd is a peptide with anti-inflammatory and analgesic properties. It was initially discovered as a potential drug candidate for the treatment of diseases such as Crohn's disease and rheumatoid arthritis. However, irgd has also been shown to have other potential benefits, such as inhibiting neurodegeneration and preventing the development of malignant tumors.
